1. Home
  2. BOH vs BLTE Comparison

BOH vs BLTE Comparison

Compare BOH & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOH
  • BLTE
  • Stock Information
  • Founded
  • BOH 1897
  • BLTE 2018
  • Country
  • BOH United States
  • BLTE United States
  • Employees
  • BOH N/A
  • BLTE N/A
  • Industry
  • BOH Major Banks
  • BLTE Biotechnology: Pharmaceutical Preparations
  • Sector
  • BOH Finance
  • BLTE Health Care
  • Exchange
  • BOH Nasdaq
  • BLTE Nasdaq
  • Market Cap
  • BOH 2.6B
  • BLTE 2.1B
  • IPO Year
  • BOH N/A
  • BLTE 2022
  • Fundamental
  • Price
  • BOH $66.82
  • BLTE $69.93
  • Analyst Decision
  • BOH Hold
  • BLTE Strong Buy
  • Analyst Count
  • BOH 5
  • BLTE 4
  • Target Price
  • BOH $72.60
  • BLTE $96.67
  • AVG Volume (30 Days)
  • BOH 476.3K
  • BLTE 45.0K
  • Earning Date
  • BOH 07-28-2025
  • BLTE 08-11-2025
  • Dividend Yield
  • BOH 4.19%
  • BLTE N/A
  • EPS Growth
  • BOH 7.02
  • BLTE N/A
  • EPS
  • BOH 3.81
  • BLTE N/A
  • Revenue
  • BOH $657,046,000.00
  • BLTE N/A
  • Revenue This Year
  • BOH $15.73
  • BLTE N/A
  • Revenue Next Year
  • BOH $7.97
  • BLTE N/A
  • P/E Ratio
  • BOH $17.54
  • BLTE N/A
  • Revenue Growth
  • BOH 3.70
  • BLTE N/A
  • 52 Week Low
  • BOH $57.45
  • BLTE $43.70
  • 52 Week High
  • BOH $82.70
  • BLTE $86.53
  • Technical
  • Relative Strength Index (RSI)
  • BOH 57.77
  • BLTE 59.16
  • Support Level
  • BOH $62.19
  • BLTE $68.99
  • Resistance Level
  • BOH $67.16
  • BLTE $74.49
  • Average True Range (ATR)
  • BOH 1.54
  • BLTE 3.27
  • MACD
  • BOH 0.54
  • BLTE 0.48
  • Stochastic Oscillator
  • BOH 95.03
  • BLTE 61.59

About BOH Bank of Hawaii Corporation

Bank of Hawaii Corp provides a broad range of financial products and services predominantly to customers in Hawaii, Guam, and other Pacific Islands. The Bank's subsidiaries are engaged in equipment leasing, securities brokerage, investment advisory services, and providing credit insurance. It is organized into three business segments for management reporting purposes: Consumer Banking, Commercial Banking, and Treasury and Other. Majority of the revenue is generated from Consumer Banking segment which offers a broad range of financial products and services, including loan, deposit and insurance products; private banking and international client banking services; trust services; investment management; and institutional investment advisory services.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: